应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IOVA Iovance Biotherapeutics, Inc.
盘前交易 05-06 05:22:50 EDT
13.63
+0.75
+5.82%
最高
13.88
最低
13.30
成交量
429.28万
今开
13.46
昨收
12.88
日振幅
4.50%
总市值
38.14亿
流通市值
28.75亿
总股本
2.80亿
成交额
5,827万
换手率
2.04%
流通股本
2.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Iovance Biotherapeutics, Inc.盘中异动 快速上涨5.01%
自选股智能写手 · 05-02
Iovance Biotherapeutics, Inc.盘中异动 快速上涨5.01%
Iovance Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.26%报11.71美元
自选股智能写手 · 04-16
Iovance Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.26%报11.71美元
Iovance Biotherapeutics, Inc.盘中异动 临近收盘股价大涨5.01%报13.21美元
自选股智能写手 · 04-12
Iovance Biotherapeutics, Inc.盘中异动 临近收盘股价大涨5.01%报13.21美元
Iovance Biotherapeutics, Inc.盘中异动 大幅跳水6.81%报12.32美元
自选股智能写手 · 04-10
Iovance Biotherapeutics, Inc.盘中异动 大幅跳水6.81%报12.32美元
Iovance Biotherapeutics, Inc.盘中异动 急速上涨5.02%
自选股智能写手 · 03-21
Iovance Biotherapeutics, Inc.盘中异动 急速上涨5.02%
Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.00%
自选股智能写手 · 03-21
Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.00%
Iovance Biotherapeutics, Inc.盘中异动 临近午盘大幅上涨5.09%报17.33美元
自选股智能写手 · 03-07
Iovance Biotherapeutics, Inc.盘中异动 临近午盘大幅上涨5.09%报17.33美元
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌5.01%报16.11美元
自选股智能写手 · 03-05
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌5.01%报16.11美元
Iovance Biotherapeutics, Inc.2023财年实现净利润-4.44亿美元,同比减少12.12%
自选股智能写手 · 03-04
Iovance Biotherapeutics, Inc.2023财年实现净利润-4.44亿美元,同比减少12.12%
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌8.20%报16.00美元
自选股智能写手 · 02-29
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌8.20%报16.00美元
Iovance Biotherapeutics Inc盘中异动 下午盘股价大涨5.00%报17.43美元
自选股智能写手 · 02-28
Iovance Biotherapeutics Inc盘中异动 下午盘股价大涨5.00%报17.43美元
Iovance Biotherapeutics Inc 预计每股亏损43美分 - 财报前瞻
Reuters · 02-27
Iovance Biotherapeutics Inc 预计每股亏损43美分 - 财报前瞻
公司概况
公司名称:
Iovance Biotherapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Iovance Biotherapeutics, Inc.是一家新兴的生物技术公司,专注于培养细胞,使用自体肿瘤浸润淋巴细胞(TIL)治疗转移性黑色素瘤等实体瘤的细胞治疗方法的发展和商业化。该公司于2007年9月17日在内华达州成立。
发行价格:
--
{"stockData":{"symbol":"IOVA","market":"US","secType":"STK","nameCN":"Iovance Biotherapeutics, Inc.","latestPrice":13.63,"timestamp":1714766400000,"preClose":12.88,"halted":0,"volume":4292824,"delay":0,"floatShares":210902848,"shares":279831972,"eps":-1.89,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.75,"latestTime":"05-06 05:22:50 EDT","open":13.46,"high":13.8799,"low":13.3,"amount":58265418.360352,"amplitude":0.045023,"askPrice":14.35,"askSize":100,"bidPrice":13.9,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-1.89,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715002200000},"adr":0,"adjPreClose":13.63,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":13.69,"preClose":13.63,"latestTime":"19:55 EDT","volume":64155,"amount":874477.6543,"timestamp":1714780531890},"volumeRatio":1.0030596325548302},"requestUrl":"/m/hq/s/IOVA/wiki","defaultTab":"wiki","newsList":[{"id":"2432633991","title":"Iovance Biotherapeutics, Inc.盘中异动 快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432633991","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432633991?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:41","pubTimestamp":1714588880,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时41分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速上涨5.01%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.63%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502024120861ea921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502024120861ea921&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427882504","title":"Iovance Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.26%报11.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427882504","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427882504?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:44","pubTimestamp":1713203040,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日01时44分,Iovance Biotherapeutics, Inc.股票出现波动,股价大幅下跌5.26%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.25%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和破坏多种癌细胞的能力,采用针对每位患者的个性化疗法,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160144007920a66f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160144007920a66f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426429751","title":"Iovance Biotherapeutics, Inc.盘中异动 临近收盘股价大涨5.01%报13.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426429751","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426429751?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:43","pubTimestamp":1712864613,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时43分,Iovance Biotherapeutics, Inc.股票出现异动,股价快速拉升5.01%。截至发稿,该股报13.21美元/股,成交量271.65万股,换手率0.97%,振幅5.64%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和破坏多种癌细胞的能力,采用针对每位患者的个性化疗法,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412034334861e5096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412034334861e5096&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426492925","title":"Iovance Biotherapeutics, Inc.盘中异动 大幅跳水6.81%报12.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426492925","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426492925?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:31","pubTimestamp":1712755894,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时31分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅下跌6.81%。截至发稿,该股报12.32美元/股,成交量42.8661万股,换手率0.15%,振幅3.48%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.15%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和破坏多种癌细胞的能力,采用针对每位患者的个性化疗法,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102131358b0a6e08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102131358b0a6e08&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421434830","title":"Iovance Biotherapeutics, Inc.盘中异动 急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421434830","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421434830?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:31","pubTimestamp":1711027879,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时31分,Iovance Biotherapeutics, Inc.股票出现波动,股价大幅拉升5.02%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和破坏多种癌细胞的能力,采用针对每位患者的个性化疗法,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212131197a4e404e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212131197a4e404e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421778023","title":"Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421778023","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421778023?lang=zh_cn&edition=full","pubTime":"2024-03-21 00:26","pubTimestamp":1710952012,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日00时26分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅拉升5.00%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.88%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和破坏多种癌细胞的能力,采用针对每位患者的个性化疗法,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321002652791bc2e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321002652791bc2e3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417214831","title":"Iovance Biotherapeutics, Inc.盘中异动 临近午盘大幅上涨5.09%报17.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417214831","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417214831?lang=zh_cn&edition=full","pubTime":"2024-03-07 00:42","pubTimestamp":1709743330,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日00时42分,Iovance Biotherapeutics, Inc.股票出现波动,股价大幅上涨5.09%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和破坏多种癌细胞的能力,采用针对每位患者的个性化疗法,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070042107a4a23b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070042107a4a23b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417448208","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌5.01%报16.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417448208","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417448208?lang=zh_cn&edition=full","pubTime":"2024-03-05 23:18","pubTimestamp":1709651920,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日23时18分,Iovance Biotherapeutics, Inc.股票出现波动,股价大幅跳水5.01%。截至发稿,该股报16.11美元/股,成交量221.022万股,换手率0.79%,振幅6.73%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.32%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和破坏多种癌细胞的能力,采用针对每位患者的个性化疗法,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403052318407a49bba7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403052318407a49bba7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416096689","title":"Iovance Biotherapeutics, Inc.2023财年实现净利润-4.44亿美元,同比减少12.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416096689","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416096689?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:25","pubTimestamp":1709483126,"startTime":"0","endTime":"0","summary":"12月31日,Iovance Biotherapeutics, Inc.公布财报,公告显示公司2023财年净利润为-4.44亿美元,同比减少12.12%;其中营业收入为1.19百万美元,每股基本收益为-1.89美元。从资产负债表来看,Iovance Biotherapeutics, Inc.总负债1.96亿美元,其中短期债务7.78百万美元,资产负债比为3.98,流动比率为2.80。机构评级:截至2023年12月31日,当前有12家机构对Iovance Biotherapeutics, Inc.目标价做出预测,其中目标均价为25.17美元,其中最低目标价为17.00美元,最高目标价为34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400253587e0e610&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400253587e0e610&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415529905","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌8.20%报16.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415529905","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415529905?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:30","pubTimestamp":1709217041,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时30分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅下跌8.20%。截至发稿,该股报16.00美元/股,成交量37.2098万股,换手率0.13%,振幅0.52%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和破坏多种癌细胞的能力,采用针对每位患者的个性化疗法,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229223041861da2b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229223041861da2b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414381503","title":"Iovance Biotherapeutics Inc盘中异动 下午盘股价大涨5.00%报17.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414381503","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414381503?lang=zh_cn&edition=full","pubTime":"2024-02-28 03:03","pubTimestamp":1709060583,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日03时03分,Iovance Biotherapeutics Inc股票出现波动,股价大幅上涨5.00%。截至发稿,该股报17.43美元/股,成交量610.09万股,换手率2.19%,振幅7.47%。Iovance Biotherapeutics Inc股票所在的生物技术行业中,整体涨幅为0.33%。Iovance Biotherapeutics Inc公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和破坏多种癌细胞的能力,采用针对每位患者的个性化疗法,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022803030487e73aa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022803030487e73aa1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414865297","title":"Iovance Biotherapeutics Inc 预计每股亏损43美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414865297","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414865297?lang=zh_cn&edition=full","pubTime":"2024-02-27 06:22","pubTimestamp":1708986158,"startTime":"0","endTime":"0","summary":" * Iovance Biotherapeutics Inc 将于2月28日公布截至2023年12月31日的财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,13位分析师的平均预期显示,这家总部位于加利福尼亚州圣卡洛斯的公司预计将实现营收139.2万美元。* LSEG 分析师对 Iovance Biotherapeutics Inc 的平均预期是每股亏损 43 美分。* 华尔街对 Iovance Biotherapeutics Inc 的 12 个月目标价中位数为 24.50 美元,高于其上次收盘价 15.77 美元。2月26日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iovance.com","stockEarnings":[{"period":"1week","weight":0.171},{"period":"1month","weight":-0.0271},{"period":"3month","weight":0.7253},{"period":"6month","weight":2.2375},{"period":"1year","weight":0.9898},{"period":"ytd","weight":0.6765}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Iovance Biotherapeutics, Inc.是一家新兴的生物技术公司,专注于培养细胞,使用自体肿瘤浸润淋巴细胞(TIL)治疗转移性黑色素瘤等实体瘤的细胞治疗方法的发展和商业化。该公司于2007年9月17日在内华达州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.066181},{"month":2,"riseRate":0.555556,"avgChangeRate":0.167188},{"month":3,"riseRate":0.2,"avgChangeRate":-0.027658},{"month":4,"riseRate":0.3,"avgChangeRate":-0.022763},{"month":5,"riseRate":0.5,"avgChangeRate":-0.008751},{"month":6,"riseRate":0.555556,"avgChangeRate":0.188177},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.007291},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.02285},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.0719},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.029093},{"month":11,"riseRate":0.777778,"avgChangeRate":0.070069},{"month":12,"riseRate":0.666667,"avgChangeRate":0.07448}],"exchange":"NASDAQ","name":"Iovance Biotherapeutics, Inc.","nameEN":"Iovance Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Iovance Biotherapeutics, Inc.(IOVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Iovance Biotherapeutics, Inc.(IOVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Iovance Biotherapeutics, Inc.,IOVA,Iovance Biotherapeutics, Inc.股票,Iovance Biotherapeutics, Inc.股票老虎,Iovance Biotherapeutics, Inc.股票老虎国际,Iovance Biotherapeutics, Inc.行情,Iovance Biotherapeutics, Inc.股票行情,Iovance Biotherapeutics, Inc.股价,Iovance Biotherapeutics, Inc.股市,Iovance Biotherapeutics, Inc.股票价格,Iovance Biotherapeutics, Inc.股票交易,Iovance Biotherapeutics, Inc.股票购买,Iovance Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Iovance Biotherapeutics, Inc.(IOVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Iovance Biotherapeutics, Inc.(IOVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}